Ritter Pharmaceuticals has appointed John W. Beck as chief financial officer. “We are pleased to add an executive of Mr. Beck’s caliber to our Company as we continue to expand and strengthen our management team during this exciting time of growth and product advancement,” said Michael D. Step, chief executive officer of the Company.  “John has an extensive track record of success at multiple life sciences companies including his role as CFO for Ardea Biosciences, Inc., which in 2012, was a...